Extended Data Fig. 2: Percentage of true positive cases in ProtecT across P-CARE categories. | Nature Cancer

Extended Data Fig. 2: Percentage of true positive cases in ProtecT across P-CARE categories.

From: Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study

Extended Data Fig. 2

Illustrated are the percentage of true positive cases for various PSA levels among 6,411 men in the ProtecT Study (all values ≥ 3 ng/mL, 3-4 ng/mL, 4-10 ng/mL, and >10 ng/mL) for clinically significant prostate cancer stratified by P-CARE risk percentiles, with comparisons between the top 5% (P-CARE95) and top 20% (P-CARE80). Error bars represent 95% confidence intervals.

Source data

Back to article page